Late-Onset Asthma in UK Adults 2026: NHS Diagnosis, MART Inhalers and Red Flags

Around 12% of UK adult asthma cases begin after the age of 18, with women in midlife particularly affected.

Around 12% of UK adult asthma cases begin after the age of 18 (Asthma + Lung UK), and adult-onset asthma is more common in women – particularly in their 40s and 50s, around perimenopause. The underlying biology is the same as childhood asthma – chronic airway inflammation causes the airways to swell and narrow – but the trigger profile, the diagnostic journey, and the treatment options can look different. This piece covers what late-onset asthma is, why it might be happening to you now, the NHS diagnostic pathway under NICE NG245 (November 2024), what 2026 treatment looks like, the red flags that mean call 999, and how to push for a proper diagnosis if you feel you are getting nowhere.

What late-onset asthma actually is

Late-onset (or adult-onset) asthma is exactly what it sounds like – asthma diagnosed for the first time in adulthood, often in middle age. The core mechanism is identical to the childhood version: chronic airway inflammation that swells and narrows the airways and makes breathing harder.

The differences are in the profile. Adult-onset asthma tends to be more persistent. It is less likely to go into remission, and it is often harder to control with first-line treatment alone. It is more common in women than men, and frequently emerges around the perimenopause and menopause years.

Asthma + Lung UK estimates around 5.4 million people in the UK currently have asthma, and a meaningful proportion of those developed it later in life rather than as children.

Symptoms – what to actually look out for

The four cardinal symptoms are the same as in childhood asthma. Wheeze – a whistling sound when you breathe out. Breathlessness, particularly with exertion or trying to sleep. A persistent dry cough, often worse at night or in the early morning. And chest tightness – a feeling of pressure or a band around the chest.

What really points at asthma rather than a one-off chest infection is the pattern. Symptoms come and go. They are often worse at night and in the early morning. They can be triggered by exercise, cold air, a viral infection, or exposure to allergens like pollen, animal dander or house dust mite. If you notice that kind of recurring, trigger-related pattern over weeks rather than days, it is time for a serious GP appointment.

Why it might be happening to you now

A few main factors unmask or trigger asthma in adulthood.

Female sex matters. Hormonal shifts around perimenopause and menopause are a recognised trigger window for new asthma in women.

Body weight matters. Obesity is an independent risk factor for adult-onset asthma.

Recent infection matters. A viral lower respiratory infection – including COVID-19, flu, RSV – can kickstart the inflammatory process. Long COVID is also recognised as a trigger of new respiratory symptoms in some adults.

Environment and work matter, too. Around 1 in 10 adult-onset asthma cases are estimated to be work-related. Occupations involving paint sprays, flour dust (bakers), cleaning agents, isocyanates (paints and foams), or latex are particular flags. If your symptoms ease on holiday or during weekends away from work, mention it to your GP – it is one of the most under-recognised drivers of adult-onset asthma.

Other adult triggers include smoking and second-hand smoke, urban air pollution, new allergen exposure (a new pet, a new home), and certain medications – NSAIDs and aspirin in some adults (aspirin-exacerbated respiratory disease) and beta-blockers.

Around 1 in 10 adult-onset asthma cases are work-related – if symptoms ease at weekends or on holiday, mention it to your GP.

How the NHS actually diagnoses it in 2026

The days of an asthma diagnosis based on history alone are over. The joint BTS / NICE / SIGN guideline NG245, published in November 2024, requires objective testing for a confirmed diagnosis in adults and children over 5.

It starts with a careful history. Your GP will ask about the pattern of symptoms, triggers, family history, smoking, occupation, and allergies.

Then come the tests. The first-line objective test is either a blood eosinophil count or a FeNO (fractional exhaled nitric oxide) test. You breathe into a small machine that measures inflammation markers in your breath. A FeNO of 50 parts per billion or higher in an adult strongly supports an asthma diagnosis.

If FeNO and eosinophil count are negative or borderline, the next test is spirometry with bronchodilator reversibility. You blow into a machine to measure lung function (FEV1), take a dose of a reliever inhaler, then repeat. An increase in FEV1 of 12% AND at least 200 mL confirms reversible airway narrowing – the hallmark of asthma.

If spirometry is not available or is delayed, the GP may ask you to record peak expiratory flow (PEF) twice daily for two weeks. Variability of 20% or more across those readings is suggestive of asthma.

For complex or borderline cases, a hospital specialist may add a bronchial challenge test. Specialist referral is the right route when the diagnosis is uncertain or when treatment response is poor.

A practical caveat worth knowing: GP access to FeNO and quality-assured spirometry is genuinely uneven across the UK. If you are getting nowhere despite suggestive symptoms, ask your GP what objective tests are available at your practice, what the local referral pathway is, and how long the wait is.

Treatment in 2026 – the major change you need to know

The biggest single shift in NICE NG245 is this: using a blue reliever inhaler (a short-acting beta-agonist, or SABA) on its own is no longer recommended for anyone aged 12 or over. SABA-only use is associated with worse outcomes and a higher exacerbation risk.

The new first-line approach uses a combination inhaler containing an inhaled corticosteroid (ICS) plus formoterol, a long-acting reliever. Two main delivery models:

AIR (Anti-Inflammatory Reliever): you use a low-dose ICS-formoterol inhaler only when you have symptoms. No regular daily preventer – the inflammation is treated each time you use the inhaler.

MART (Maintenance And Reliever Therapy): you take a low- or medium-dose ICS-formoterol inhaler regularly twice a day, and also use the same inhaler as your reliever when symptoms flare.

If symptoms remain uncontrolled, the next step is medium-dose MART. After that, a GP can add another drug class – a long-acting muscarinic antagonist (LAMA) such as tiotropium, or a leukotriene receptor antagonist (LTRA) such as montelukast.

For severe, uncontrolled asthma, hospital specialists can prescribe biologic therapies (omalizumab, mepolizumab, benralizumab, dupilumab, tezepelumab) targeting specific parts of the immune response. These are specialist-clinic prescriptions, not GP-issued.

Some practical points worth flagging. Use a spacer device with a metered-dose inhaler (MDI) – it improves drug delivery into the lungs. Inhaler technique should be checked at every appointment – poor technique is one of the leading causes of poor control. You are entitled to a free annual flu jab on the NHS if you have asthma. COVID-19 boosters follow current JCVI guidance. If you smoke, ask for a referral to NHS Quit Your Way / Help Me Quit / your local stop-smoking service.

Your annual NHS asthma review and action plan

Asthma management is a partnership, and the NHS has a framework for it. The Quality and Outcomes Framework (QOF) means your GP practice should offer you a yearly asthma review. That appointment is your check-in. It should cover symptom control over the last year, an inhaler-technique check, a medication review, smoking and vaccination status, and any new triggers.

Importantly, you should leave that review with a personalised written asthma action plan. It is a simple document – normally a single sheet – that you and your GP or asthma nurse fill in together. It sets out your daily preventer routine, what to do if symptoms start to worsen (for example, increasing your MART dose), and the precise red flags that mean to call 999.

If you have never had a written action plan, or you cannot remember the last time you had a proper review, ask your practice. It is your right under QOF.

When to call 999 and when to see your GP soon

Knowing the difference between a flare-up and a life-threatening attack matters.

See your GP within a few days if:

• You have a new persistent cough, wheeze, breathlessness or chest tightness lasting more than a few weeks.
• Symptoms keep recurring after chest infections.
• Symptoms regularly wake you at night.
• If you are already diagnosed, you are needing your reliever inhaler more than three times a week.

Frequently Asked Questions

Last updated: 10 May 2026. Treatment and diagnostic guidance follows BTS / NICE / SIGN NG245 (November 2024) and Asthma + Lung UK information.